LUPUS ANTICOAGULANT - A POTENTIAL RISK FACTOR FOR COMPLICATION FOLLOWING PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY

被引：7

作者：

ANGLIN, P

STRAUSS, BH

BRANDWEIN, JM

WATSON, KR

机构：

[1] ST MICHAELS HOSP, DIV CARDIOL, TORONTO M5B 1W8, ON, CANADA

[2] ST MICHAELS HOSP, DIV HEMATOL, TORONTO M5B 1W8, ON, CANADA

来源：

CATHETERIZATION AND CARDIOVASCULAR DIAGNOSIS | 1994年 / 31卷 / 02期

关键词：

ABRUPT CLOSURE; CORONARY ANGIOPLASTY; LUPUS ANTICOAGULANT;

D O I：

10.1002/ccd.1810310208

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

A patient is described with antiphospholipid antibodies who died approximately 24 hr after an uncomplicated balloon angioplasty. Since the literature suggests a relationship between the presence of antiphospholipid antibodies and thromboses, we suggest that these antibodies may be a risk factor for abrupt closure after percutaneous transluminal coronary angioplasty. (C) 1994 Wiley-Liss, Inc.

引用

收藏

页码：130 / 132

页数：3

相关论文

共 18 条

[1] PRESENCE OF COMPLEMENT-FIXING ANTI-ENDOTHELIAL CELL ANTIBODIES IN SYSTEMIC LUPUS-ERYTHEMATOSUS [J].

CINES, DB ;

LYSS, AP ;

REEBER, M ;

BINA, M ;

DEHORATIUS, RJ .

JOURNAL OF CLINICAL INVESTIGATION, 1984, 73 (03) :611-625

[2]

DACIE J, 1991, PRACTICAL HAEMATOLOG, P323

[3] ACUTE CORONARY-ARTERY OCCLUSION DURING AND AFTER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY - FREQUENCY, PREDICTION, CLINICAL COURSE, MANAGEMENT, AND FOLLOW-UP [J].

DEFEYTER, PJ ;

VANDENBRAND, M ;

JAARMAN, G ;

VANDOMBURG, R ;

SERRUYS, PW ;

SURYAPRANATA, H .

CIRCULATION, 1991, 83 (03) :927-936

[4] INCIDENCE AND CONSEQUENCES OF PERIPROCEDURAL OCCLUSION - THE 1985-1986 NATIONAL HEART, LUNG, AND BLOOD INSTITUTE PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY REGISTRY [J].

DETRE, KM ;

HOLMES, DR ;

HOLUBKOV, R ;

COWLEY, MJ ;

BOURASSA, MG ;

FAXON, DP ;

DORROS, GR ;

BENTIVOGLIO, LG ;

KENT, KM ;

MYLER, RK .

CIRCULATION, 1990, 82 (03) :739-750

[5] CORONARY MORPHOLOGICAL AND CLINICAL DETERMINANTS OF PROCEDURAL OUTCOME WITH ANGIOPLASTY FOR MULTIVESSEL CORONARY-DISEASE - IMPLICATIONS FOR PATIENT SELECTION [J].

ELLIS, SG ;

VANDORMAEL, MG ;

COWLEY, MJ ;

DISCIASCIO, G ;

DELIGONUL, U ;

TOPOL, EJ ;

BULLE, TM .

CIRCULATION, 1990, 82 (04) :1193-1202

[6]

FEINSTEIN DI, 1991, HEMATOLOGY BASIC PRI, P1385

[7] LUPUS ANTICOAGULANT - AN ANALYSIS OF THE CLINICAL AND LABORATORY FEATURES OF 219 CASES [J].

GASTINEAU, DA ;

KAZMIER, FJ ;

NICHOLS, WL ;

BOWIE, EJW .

AMERICAN JOURNAL OF HEMATOLOGY, 1985, 19 (03) :265-275

[8] ANTICARDIOLIPIN ANTIBODIES AND THE RISK FOR ISCHEMIC STROKE AND VENOUS THROMBOSIS [J].

GINSBURG, KS ;

LIANG, MH ;

NEWCOMER, L ;

GOLDHABER, SZ ;

SCHUR, PH ;

HENNEKENS, CH ;

STAMPFER, MJ .

ANNALS OF INTERNAL MEDICINE, 1992, 117 (12) :997-1002

[9]

HAMSTEN A, 1986, LANCET, V1, P113

[10] ANTIPHOSPHOLIPID ANTIBODIES - AUTOANTIBODIES WITH A DIFFERENCE [J].

HARRIS, EN ;

ASHERSON, RA ;

HUGHES, GRV .

ANNUAL REVIEW OF MEDICINE, 1988, 39 :261-271